These findings indicated that type 2 diabetes enhanced apoptosis in mouse kidneys, but PPAR-α agonist fenofibrate treatment prevented apoptosis in mouse kidneys of type 2 diabetes. Here, PPARA is linked to type 2 diabetes mellitus.